 |
Languages: |
|
OTCMarket2000.com Corporate Goods, Products and Services - Pharmaceutical | ||
|
Symbol: ADGI
Company Name: American Diversified Group Inc. Contact Person: Jerrold R. Hinton Pres./CEO/CFO.
Company Description: ADGI is a developstage company with intentions to acquire; develop; distribute and/or market medical products; including generic pharmaceuticals; vitamins; blood derivative products and diagnostic test kits principally for the export market.
Symbol: MLSC
Company Name: Medical Discoveries Inc. Contact Person: David Walker Chmn, Lee F. Kulas
Pres./CEO. Website: Company Description: MLSC is a development stage bio-pharmaceutical company that has developed a technology (MDI-P) that appears to have the ability to destroy certain viruses & bacteria.
Symbol: APPI
Company Name: Advanced Plant Pharmaceuticals Inc. Contact Person: Barry
Clare Website: www.advancedplantpharm.com Company Description: APPI is a company that develops innovative plant formulations and technology for clinical application. APPI has met the FDA nutritional specifications for the marketing of its Cholesterol lowering agent “Lo-Chol” in the USA. The Company is also developing a product Abaca/ACA which has potential as an immunomodulator in treatment of HIV. ACA is being explored for the use in the fight of CFS (Chronic Fatigue Syndrome).
Symbol: KAHI
Company Name: Kaire Holdings Inc. (Vita Planet.Com; Subsid. of KAHI) Contact Person: Owen
Naccarato Company Description: KAHI develops makes markets and licenses colored micropheres used in connection with the imaging of human organs, in the measurement of blood flow in animals,and in the development of dietary food products, and fat sequestrant products which promote weight loss.
Symbol: DYGN
Company Name: DynaGen Inc. Contact Person: Indu A. Muni Ph.D
Pres./CEO/Treas./CFO/CAO. Company Description: DYGN through its subsidiaries, Able Laboratories Inc., Superior Pharmaceutical Company, Generic Distributors Inc., and Apex Pharmaceuticals develops manufactures and distributes generic pharmaceuticals.
Symbol: VRGN
Company Name: Viragen Inc. Contact Person: Gerald Smith,Chmn./Pres; Robert
Zeiger,CEO. Company Description: VRGN researches, develops and manufactures certain immunological products for commercial applications, particularly human leukocyte interferon, for antirival and theraputic applications as well as anti-cancer agents. | ||
